Cyclooxygenase regulates cell surface expression of CXCR3/1-storing granules in human CD4+ T cells

Journal of Immunology

Volumn 177, Issue 12, 2006, Pages 8806-8812

  Gasser, Olivier ^a   Schmid, Thomas A ^a   Zenhaeusern, Gabriela ^a   Hess, Christoph ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ARACHIDONIC ACID; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR3; CYCLOHEXIMIDE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHALASIN D; FR 122047; IBUPROFEN; INDOMETACIN; NORDIHYDROGUAIARETIC ACID; PHYTOHEMAGGLUTININ; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SC 791; T LYMPHOCYTE RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL GRANULE; CELL SURFACE; CHEMOTAXIS; CONCENTRATION RESPONSE; ENZYME SUBSTRATE; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNITY; LYMPHOCYTE MIGRATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION;

EID: 33845410119     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.12.8806     Document Type: Article

References (49)

1. + T lymphocytes. Nature 421: 852-856.
2. + T cell responses. Curr. Opin. Immunol. 16: 259-263.
3. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
4. + T cells after acute infection. Nat. Immunol. 5: 927-933.
5. Khanolkar, A., M. J. Fuller, and A. J. Zajac. 2004. CD4 T cell-dependent CD8 T cell maturation. J. Immunol. 172: 2834-2844.
6. Campbell, D. J., C. H. Kim, and E. C. Butcher. 2001. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat. Immunol. 2: 876-881.
7. + T cells. J. Exp. Med. 193: 1373-1381.
8. Zimmermann, N., G. K. Hershey, P. S. Foster, and M. E. Rothenberg. 2003. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J. Allergy Clin. Immunol. 111: 227-242.
9. + T cells. Curr. Opin. Immunol. 15: 336-342.
10. Schaerli, P., M. Britschgi, M. Keller, U. C. Steiner, L. S. Steinmann, B. Moser, and W. J. Pichler. 2004. Characterization of human T cells that regulate neutrophilic skin inflammation. J. Immunol. 173: 2151-2158.
11. Ansel, K. M., and J. G. Cyster. 2001. Chemokines in lymphopoiesis and lymphoid organ development. Curr. Opin. Immunol. 13: 172-179.
12. Campbell, D. J., G. F. Debes, B. Johnston, E. Wilson, and E. C. Butcher. 2003. Targeting T cell responses by selective chemokine receptor expression. Semin. Immunol. 15: 277-286.
13. Cyster, J. G. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286: 2098-2102.
14. Cyster, J. G., V. N. Ngo, E. H. Ekland, M. D. Gunn, J. D. Sedgwick, and K. M. Ansel. 1999. Chemokines and B cell homing to follicles. Curr. Top. Microbiol. Immunol. 246: 87-92.
15. Cyster, J. G. 2003. Lymphoid organ development and cell migration. Immunol. Rev. 195: 5-14.
16. Luster, A. D. 2002. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14: 129-135.
17. Warnock, R. A., J. J. Campbell, M. E. Dorf, A. Matsuzawa, L. M. McEvoy, and E. C. Butcher. 2000. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J. Exp. Med. 191: 77-88.
18. Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig, C. R. Mackay, S. Qin, and A. Lanzavecchia. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28: 2760-2769.
19. 4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4: 982-990.
20. 4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. Blood 15: 444-453.
21. Luster, A. D., and A. M. Tager. 2004. T cell trafficking in asthma: lipid mediators grease the way. Nat. Rev. Immunol. 4: 711-724.
22. 4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 4: 965-973.
23. Samuelsson, B., S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176.
24. Jakobsson, P. J., D. Steinhilber, B. Odlander, O. Radmark, H. E. Claesson, and B. Samuelsson. 1992. On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc. Natl. Acad. Sci. USA 89: 3521-3525.
25. + T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 20: 219-230.
26. Sampath, P., and T. D. Pollard. 1991. Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochemistry 30: 1973-1980.
27. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
28. Lanzavecchia, A., and F. Sallusto. 2005. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17: 326-332.
29. Monleon, I., M. J. Martinez-Lorenzo, A. Anel, P. Lasierra, L. Larrad, A. Pineiro, J. Naval, and M. A. Alava. 2000. CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells. Eur. J. Immunol. 30: 1078-1087.
30. Rossi Paccani, S., M. Boncristiano, and C. T. Baldari. 2003. Molecular mechanisms underlying suppression of lymphocyte responses by nonsteroidal antiinflammatory drugs. Cell. Mol. Life Sci. 60: 1071-1083.
31. Paccani, S. R., L. Patrussi, C. Ulivieri, J. L. Masferrer, M. M. D'Elios, and C. T. Baldari. 2005. Nonsteroidal anti-inflammatory drugs inhibit a Fyn-dependent pathway coupled to Rac and stress kinase activation in TCR signaling. Blood 105: 2042-2048.
32. Paccani, S. R., M. Boncristiano, C. Ulivieri, M. M. D'Elios, G. Del Prete, and C. T. Baldari. 2002. Nonsteroidal anti-inflammatory drugs suppress T cell activation by inhibiting p38 MAPK induction. J. Biol. Chem. 277: 1509-1513.
33. Johnson, Z., C. A. Power, C. Weiss, F. Rintelen, H. Ji, T. Ruckle, M. Camps, T. N. Wells, M. K. Schwarz, A. E. Proudfoot, and C. Rommel. 2004. Chemokine inhibition-why, when, where, which and how? Biochem. Soc. Trans. 32: 366-377.
34. Glimcher, L. H., M. J. Townsend, B. M. Sullivan, and G. M. Lord. 2004. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 4: 900-911.
35. Swanson, B. J., M. Murakami, T. C. Mitchell, J. Kappler, and P. Marrack. 2002. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 17: 605-615.
36. + memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J. Exp. Med. 181: 1293-1301.
37. Chklovskaia, E., W. Jansen, C. Nissen, S. D. Lyman, C. Rahner, L. Landmann, and A. Wodnar-Filipowicz. 1999. Mechanism of flt3 ligand expression in bone marrow failure: translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis. Blood 93: 2595-2604.
38. + T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation. Blood 106: 3718-3724.
39. Wagner, L., O. O. Yang, E. A. Garcia-Zepeda, Y. Ge, S. A. Kalams, B. D. Walker, M. S. Pasternack, and A. D. Luster. 1998. β-Chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391: 908-911.
40. Faurschou, M., and N. Borregaard. 2003. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5: 1317-1327.
41. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187: 129-134.
42. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187: 875-883.
43. + T cells in human allergic disease. J. Immunol 172: 268-273.
44. Zhang, Z., L. Kaptanoglu, Y. Tang, D. Ivancic, S. M. Rao, A. Luster, T. A. Barrett, and J. Fryer. 2004. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection. Gastroenterology 126: 809-818.
45. Hancock, W. W., W. Gao, V. Csizmadia, K. L. Faia, N. Shemmeri, and A. D. Luster. 2001. Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193: 975-980.
46. Hancock, W. W., L. Wang, Q. Ye, R. Han, and I. Lee. 2003. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr. Opin. Immunol. 15: 479-486.
47. Flier, J., D. M. Boorsma, P. J. van Beek, C. Nieboer, T. J. Stoof, R. Willemze, and C. P. Tensen. 2001. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J. Pathol. 194: 398-405.
48. Mohan, K., E. Cordeiro, M. Vaci, C. McMaster, and T. B. Issekutz. 2005. CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets. Eur. J. Immunol. 35: 1702-1711.
49. Fiorina, P., M. J. Ansari, M. Jurewicz, M. Barry, V. Ricchiuti, R. N. Smith, S. Shea, T. K. Means, H. Auchincloss, Jr., A. D. Luster, et al. 2006. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J. Am. Soc. Nephrol. 17: 716-723.